Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.
Coronary diseaseSponsored Symposia

SOLACI-CACI 2021 | Using the MLD MAX Algorithm in OCT-Guided PERCUTANEOUS CORONARY INTERVENTIONS – ABBOTT Symposium

solaci
solaci
640
0

✔️ Watch again the ABBOTT Symposium in the SOLACI-CACI 2021 Virtual Congress.
✔️ Topic: Using the MLD MAX Algorithm in OCT-Guided Percutaneous Coronary Interventions.

👨‍🏫 Program:

  • 00:05 – Introduction- Dr. Alejandro Cherro (ARG).
  • 02:34 – Concepts on the Treatment of Complex and Challenging Optical Coherence Tomography (OCT) – Guided Cases Using MLD MAX – Dr. Natalia Pinilla (CAN), Dr. Jorge Chavarría (COS / CAN) – Discussion of a Clinical Case.

👉 Moderator: Dr. Alejandro Cherro (ARG).
👉 Speakers: Dr. Natalia Pinilla (Canada), Dr. Jorge Chavarría (Costa Rica/Canada)

This event took place on August 3rd, 2021.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-CACI 2021 | Overcoming Challenges of the BALLOON EXPANDABLE TAVI Cases – EDWARDS Symposium
Next article
SOLACI-CACI 2021 | SELUTION SLR DEB – Changing the Treatment Paradigm for Complex Lesions – Medalliance Symposium
solaci
solaci

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

Dr. Omar Tupayachi - 0
The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

Dr. Omar Tupayachi - 0
In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

solaci - 0
This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

Dr. Andrés Rodríguez - 0
This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Chronic Ischemic cardiopathy

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding...
Dr. Omar Tupayachi -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Dr. Juan Manuel Pérez - 0
Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

Dr. Juan Manuel Pérez - 0
The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

Dr. Andrés Rodríguez - 0
This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...